US Patent 8470324 Fusion polypeptides capable of activating receptors
Patent 8470324 was granted and assigned to Regeneron Pharmaceuticals, Inc. on June, 2013 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8470324 Fusion polypeptides capable of activating receptors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.